Why the study?
What is the prevalence of blood lipid abnormalities and its association with BMI and fasting blood glucose in a health examination population in Beijing?
What is the prevalence of blood lipid abnormalities and its association with BMI and fasting blood glucose in a health examination population in Beijing?
In a large health examination cohort in Beijing, blood lipid abnormalities are increasingly prevalent and strongly associated with higher BMI and abnormal fasting blood glucose.
Answers are grounded in this paper and cite their sources.
Supports lipid monitoring in overweight groups; leaves open causality and need for prospective validation in Beijing cohorts.
OBJECTIVE: To investigate the prevalence of abnormity of blood lipid and associated factors in healthy population in Beijing. METHODS: Totally, 38462 individuals who received health examination were enrolled in our study. We divided them into eight groups according to their ages. The levels of serum total cholesterol, triglyceride, high density lipoprotein cholesterol, and low density lipoprotein cholesterol were tested, and the relationship of blood lipid abnormity with body mass index (BMI) and fasting blood glucose was analyzed. RESULTS: The incidences of hypercholesterolemia, hyperglyceridemia, low high-density lipoprotein cholesterolemia, and hyper low-density lipoprotein cholesterolemia presented increasing trend in this population. The incidence rate of abnormity of blood lipid in health examination population increased with BMI increase. The incidence of abnormity of blood lipid in overweight and obesity population was significantly higher than that in low weight and normal weight populations (P<0.05). Meanwhile, the trend of abnormal blood lipid incidence coincided with that of abnormal fasting blood glucose. CONCLUSIONS: The prevalence of overweight, obesity, and abnormity of blood lipid in Beijing presents increasing trend. The incidence of abnormity of blood lipid increases with BMI increase, in coincidence with that of fasting blood glucose.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: